Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Origin Agritech Announces Breakthrough in High-Yield Corn Production Through Gene Editing 2024-03-20 20:00
SGO 2024 | The First Published Clinical Data of Nectin-4-Targeting ADC Developed by Mabwell in Cervical Cancer Demonstrates Its Outstanding Therapeutic Potential 2024-03-19 22:00
Breakthrough in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion: Release of Positive Results from Multicenter Phase III Global Clinical Study 2024-03-19 10:24
Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC 2024-03-19 08:00
Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal 2024-03-18 21:00
WuXi AppTec Revenue Surpassed RMB40 Billion in 2023, and Adjusted Non-IFRS Net Profit Exceeded RMB10 Billion for the First Time 2024-03-18 20:32
Positive results from Phase II clinical trial (CGZ203 study) of Chiglitazar monotherapy for non-alcoholic steatohepatitis 2024-03-18 19:25
KeChow Pharma Announces NMPA Approval of Tunlametinib (HL-085) as the First Targeted Therapy for Patients with NRAS Mutated Advanced Melanoma and Previously Treated with PD-1/PD-L1 2024-03-18 18:02
ImmVira's oncolytic product MVR-T3011 IT Intratumoral Injection Receives FDA Fast Track Designation for HNSCC Treatment 2024-03-15 13:56
Biotheus Expanded Their Partnership with Hansoh Pharma for Developing EGFR/cMET Bispecific Antibody-Drug Conjugates 2024-03-15 12:34
I-Mab Reports Full Year 2023 Financial Results and Business Update 2024-03-15 05:00
D3 Bio Appoints Dr. Antoine Yver as Independent Board Member 2024-03-14 22:30
Study of Kintor's c-Myc Degrader Published in Subsidiary Journal of Nature 2024-03-14 12:22
YolTech Therapeutics to Showcase Breakthroughs in in vivo Gene Editing at TIDES Asia 2024 2024-03-13 20:00
Sanyou Biopharmaceuticals Launches Advanced Intelligent R&D Service Platform 2024-03-13 09:00
Mabwell to Present Pre-clinical Results at the 2024 American Association for Cancer Research (AACR) Annual Meeting 2024-03-12 22:00
GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30% 2024-03-12 20:15
Longbio Pharma Presented Positive Phase 1 Results for LP-003 at 2024AAD 2024-03-12 20:00
Mabwell to Present ADC Platform IDDC™ and the Latest Study Results of Multiple Novel ADCs at the 14th World ADC London 2024-03-11 22:00
Medicilon has appointed Dr. Qingcong Lin as President of Medicilon USA Corp., further deepening the global strategic layout 2024-03-11 20:30
1 23 24 25 26 27 222